BioHealth News
From Genomic Tests to AI Predictions: Dr. Amrie Grammer, Co-Founder of AMPEL BioSolutions, Joins BioTalk
Can you envision a world where precision medicine transforms healthcare as we know it? Tune in to this exciting episode of BioTalk with Rich…
Read More
Virginia Catalyst Announces AMPEL as Grant Round 14 Awardee
RICHMOND, VA – May 18, 2023 – The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it…
Read More
PQE Group US Earns 2023 Great Place To Work Certification™
PQE Group receives certification in the U.S. as a work environment where “you trust the people you work for, take pride in what you…
Read More
Baltimore’s Flavocure Biotech Announces FDA Clearance of IND Application for Caflanone (FBL-03G), for Clinical Trials in Pancreatic Cancer Patients.
Baltimore, Maryland--(Newsfile Corp. - May 17, 2023) - Flavocure Biotech, Inc. ("Flavocure"), today announced that it has received clearance of its Investigational New Drug…
Read More
REGENXBIO Announces NAV® Technology Platform Will Support Bespoke Gene Therapy Consortium’s First Rare Disease Clinical Portfolio
ROCKVILLE, Md., May 16, 2023 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that preclinical research in Mucopolysaccharidosis type IVA (MPS IVA), also known…
Read More
Role of global public sector research in discovering new drugs and vaccines
Analysis of international public-sector contributions to Food and Drug Administration (FDA)-approved drugs and vaccines allows for a more thorough examination of the global biomedical…
Read More
President Biden Announces Intent to Nominate Dr. Monica Bertagnolli as Director of the National Institutes of Health
Today (May 15, 2023), President Biden announced his intent to nominate Dr. Monica Bertagnolli as Director of the National Institutes of Health (NIH), the…
Read More
BHI/NIH EIR Anna Zornosa Moderates Panel of Experts: Unlocking Reimbursement for Innovators in Maternal Health Solutions
Reimbursement is key to the success of innovators who have products, therapies, and new modes of service for expectant and new mothers. Not only…
Read More
BHI’s EIR Ethel Rubin, Ph.D., Joins JLABS @ NYC Roundtable
Ethel Rubin, Ph.D., an Entrepreneur-in-Residence at BioHealth Innovation, Inc. (BHI), recently participated in a “CEO Roundtable” for JLABS @ NYC. The discussion revolved around…
Read More
BHI EIR Renée JG Arnold Shares Expertise at the 28th Annual International ISPOR Meeting
Renée JG Arnold, PharmD, RPh, who serves as an Entrepreneur-in-Residence at BHI NHLBI EIR, recently moderated and participated in a panel discussion at the…
Read More
Women In Bio announces appointment of Gina Ford as Executive Director
Women In Bio is proud to announce that Gina Ford has joined our team as Executive Director. Gina brings a wealth of experience, having worked in…
Read More
Join AURP in Boston for a Deep Dive into Building Communities of “Biotech Innovation”!
Join AURP in Boston for a Deep Dive into Building Communities of Biotech Innovation! Before the 2023 BIO International Conference begins in Boston, the…
Read More
Navigating the Challenges of Rare Disease Research with Dr. Harsha Rajasimha on BioTalk
Join us for an enlightening episode of BioTalk with Rich Bendis as we explore the pivotal role of patient registries in rare disease research…
Read More
Raising Awareness: Indo US Bridging RARE Summit 2023 to Shine a Spotlight on Rare Diseases
Scheduled for October 29-30, 2023, at the George Mason University Campus in Arlington, VA, the Indo US Bridging RARE Summit 2023 aims to unite…
Read More
Rockville’s MaximBio Inks Contract with National Institutes of Health (RADx) Centered on a new Rapid Platform
ROCKVILLE, Md. , May 9, 2023 /PRNewswire/ -- MaximBio® is proud to announce it has signed a new agreement with the National Institutes of Health (NIH) through the Rapid Acceleration…
Read More